Price
CHART BY
Frequently asked questions
What is Sensus Hlthcr's market capitalization?
The market capitalization of Sensus Hlthcr is $51.86M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for Sensus Hlthcr?
Sensus Hlthcr's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$0.943. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Sensus Hlthcr's stock?
Currently, 4 analysts cover Sensus Hlthcr's stock, with a consensus target price of $5.375. Analyst ratings provide insights into the stock's expected performance.
What is Sensus Hlthcr's revenue over the trailing twelve months?
Over the trailing twelve months, Sensus Hlthcr reported a revenue of $17.51M.
What is the EBITDA for Sensus Hlthcr?
Sensus Hlthcr's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$12.63M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Sensus Hlthcr?
Sensus Hlthcr has a free cash flow of -$6.97M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Sensus Hlthcr have, and what sector and industry does it belong to?
Sensus Hlthcr employs approximately 60 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
What is the free float of Sensus Hlthcr's shares?
The free float of Sensus Hlthcr is 13.39M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $51.86M
- EPS (TTM)
- -$0.943
- Free Float
- 13.39M
- Revenue (TTM)
- $17.51M
- EBITDA (TTM)
- -$12.63M
- Free Cashflow (TTM)
- -$6.97M
Pricing
- 1D span
- $3.11$3.178
- 52W span
- $2.67$5.45
Analyst Ratings
The price target is $5.375 and the stock is covered by 4 analysts.
Buy
4
Hold
0
Sell
0
Information
Sensus Healthcare, Inc. is a medical device company, which engages in the provision of treatment for both oncological and non-oncological skin conditions. The company was founded by Joseph C. Sardano, Richard Golin, Kalman Fishman, and Stephen Cohen on May 7, 2010 and is headquartered in Boca Raton, FL.
- Employees
- 60
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- Primary Ticker
- SRTS
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet